Related references
Note: Only part of the references are listed.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Sex Differences in Outcomes After STEMI Effect Modification by Treatment Strategy and Age
Edina Cenko et al.
JAMA INTERNAL MEDICINE (2018)
Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mgp. o. in ACS (ACUTE)
Uwe Zeymer et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association (vol 135, pg e146, 2017)
Benjamin
CIRCULATION (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016
Derek P. Chew et al.
HEART LUNG AND CIRCULATION (2016)
Chest pain, dyspnea and other symptoms in patients with type 1 and 2 myocardial infarction. A literature review
Giuseppe Lippi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction
Mark R. Thomas et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials
Davide Capodanno et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)
Epidemiology of coronary heart disease and acute coronary syndrome
Fabian Sanchis-Gomar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial
Nicolas Girerd et al.
EUROPEAN HEART JOURNAL (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Guido Parodi et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2015)
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
Francesco Costa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction A Comparison With the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) Bleeding Classifications
Wouter J. Kikkert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-Term Survival and Recurrence After Acute Myocardial Infarction in England, 2004 to 2010
Kate Smolina et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
Johanne Silvain et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Benefit of Transferring ST-Segment-Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase
Duane S. Pinto et al.
CIRCULATION (2011)
Trends in Coronary Revascularization in the United States From 2001 to 2009 Recent Declines in Percutaneous Coronary Intervention Volumes
Robert F. Riley et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
Clara K. Chow et al.
CIRCULATION (2010)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R. Mehta et al.
LANCET (2010)
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
Xavier Bosch et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial
Chris Adamopoulos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys et al.
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis
Roberto R. Giraldez et al.
EUROPEAN HEART JOURNAL (2007)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
ABC of interventional cardiology - Acute coronary syndrome: ST infarction segment elevation myocardial infarction
ED Grech et al.
BRITISH MEDICAL JOURNAL (2003)
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
EC Keeley et al.
LANCET (2003)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
EUROPEAN HEART JOURNAL (2000)
Share Paper
